Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.JAIP.2019.01.024 | ||||
| Año | 2019 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Specific antibody deficiency (SAD) is defined as the inability to mount an antibody response to purified Streptococcus pneumoniae capsular polysaccharide antigens in the presence of normal immunoglobulin concentrations and normal antibody responses to protein antigens. In this review, we discuss the difficulties in using presently available testing methods to adequately define SAD. The fact that there are different forms of SADs to pneumococcal surface polysaccharides is detailed. The diagnostic and therapeutic implications of recognizing that, in addition to SAD, there are other forms of SAD in the response to S. pneumoniae polysaccharides are described in detail. The conclusion of this review is that assessment of immunity and therapeutic actions to deal with SADs need to be based on clinical evidence rather than solely on arbitrarily defined antibody responses. (C) 2019 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Sorensen, R. | Hombre |
Louisiana State Univ - Estados Unidos
Louisiana Primary Immunodeficiency Network - Estados Unidos Universidad de La Frontera - Chile LSUHSC School of Medicine - Estados Unidos LSU Health New Orleans School of Medicine - Estados Unidos |
| 2 | Edgar, David | Hombre |
Belfast Hlth & Social Care Trust - Reino Unido
Queens Univ Belfast - Reino Unido Queen's University Belfast - Reino Unido Royal Victoria Hospital Belfast - Reino Unido |